The following parameters are evaluated during the preformulation process:

• Solubility in different media and solvents
• Dissolution of the active pharmaceutical ingredient (API)
• Accelerated Stability Services
• Solid state properties (ex. polymorphs, particle size and shape)
• Formulation services and capabilities
• Formulation development of new chemical entities (NCE)
• Optimization of existing formulations
• Process development for selected dosage forms
• Novel formulations for improved delivery of existing dosage forms
• Controlled release and sustained release formulations
• Self-emulsifying drug delivery systems
• Colloidal drug delivery systems
• Sub-micron and nano-emulsions